Back to Journals » Drug Design, Development and Therapy » Volume 13

Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura

Total article views   HTML views PDF downloads Totals
17,967 Dovepress* 13,254+ 1,673 14,927
PubMed Central* 4,713 1,192 5,905
Totals 17,967 2,865 20,832
*Since 17 April 2019
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar